Respiratory virus updates: Influenza immunity research and COVID-19 variants

Recent scientific research and health updates highlight the complexities of respiratory viruses like influenza and COVID-19. A study conducted on mice has provided new insights into why traditional influenza vaccines may not prevent all infections. While vaccines effectively reduce severe illness, they are less efficient at blocking the virus at entry points like the nose and throat. The research suggests that monocytes, previously thought to be temporary immune cells, play a crucial role in establishing long-term resident T-cell memory in the lungs, which provides rapid protection against reinfection.

In Italy, health officials are monitoring several COVID-19 variants, including XEC, Nimbus, and Stratus. While the current situation remains stable and under control, symptoms such as sore throat, fever, cough, and fatigue are being reported. Experts emphasize the importance of vaccination and hygiene measures, noting that while isolation is no longer mandatory, precautions like hand disinfection and the use of FFP2 masks in crowded areas or care facilities remain recommended to protect vulnerable populations.